Docosatrienoic Acid  (Synonyms: cis-13,16,19-docosatrienoic acid; (13Z,16Z,19Z)-13,16,19-Docosatrienoic acid)

Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an K_i of 5 μM.

Ki: 5 μM (LTB4)^[1]

Docosatrienoic acid inhibits LTB4 binding to pig neutrophil membranes with an K_i of 5 μM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Application of docosatrienic acid dose-dependently decreases the peak K⁺ current amplitide and accelerates the potassium activation and inactivation kinetics at all rat membrane potentials^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

334.54

C₂₂H₃₈O₂

28845-86-5

Liquid

Colorless to light yellow

CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(O)=O

Room temperature in continental US; may vary elsewhere.

Solution, -20°C, 2 years

• [1]. Yagaloff KA, et al. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):293-7.  [Content Brief]

  [2]. Krutetskaia ZI, et al. The effect of docosatrienoic acid on the potassium channels of outward rectification in the membrane of rat peritoneal macrophages. Fiziol Zh Im I M Sechenova. 1995 Jul;81(7):111-9.  [Content Brief]